Loading category…
Loading category…
PlasmaGen Biosciences raised INR 150 crore in a new funding round. ViNS Bioproducts led it. HNIs, family offices, pharma entrepreneurs, and existing investors joined in.
PsiThera closed a $47.5 million Series A round. Samsara Biocapital and Lightstone Ventures led. Eric Shaff joins as new CEO.
EpilepsyGTx raised $33 million in Series A funding. XGEN Venture, British Business Bank invested. Funds advance EPY201 through Phase I/IIa trials.